NCT00277056

Brief Summary

Dysregulated Tyrosine Kinase Signaling in Leukemia

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started May 2002

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2002

Completed
3.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2005

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2005

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

January 11, 2006

Completed
2 days until next milestone

First Posted

Study publicly available on registry

January 13, 2006

Completed
Last Updated

February 7, 2024

Status Verified

February 1, 2024

Enrollment Period

3.4 years

First QC Date

January 11, 2006

Last Update Submit

February 5, 2024

Conditions

Leukemia

Keywords

leukemia

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

people with leukemia

You may qualify if:

  • Patients must have newly diagnosed or relapsed leukemia.
  • Patients must sign an informed consent.
  • Patients will not be excluded if they are receiving chemotherapy.
  • Patients with CML, AML, ALL, T/NK leukemia, myelodysplasia, or myeloproliferative disorders will be eligible.
  • Patients must be =\> 18 years of age.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of New Mexico

Albuquerque, New Mexico, 87131, United States

Location

Biospecimen

Retention: SAMPLES WITH DNA

blood bone marrow

MeSH Terms

Conditions

Leukemia

Condition Hierarchy (Ancestors)

Neoplasms by Histologic TypeNeoplasmsHematologic DiseasesHemic and Lymphatic Diseases

Study Officials

  • Ian Rabinowitz, MD

    University of New Mexico

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 11, 2006

First Posted

January 13, 2006

Study Start

May 1, 2002

Primary Completion

October 1, 2005

Study Completion

October 1, 2005

Last Updated

February 7, 2024

Record last verified: 2024-02

Locations

US(1)